| Jawed Ehsan, MD | |
|
1100 Larkin Ave, Elgin, IL 60123-5272 | |
| (847) 742-0165 | |
| (847) 742-0190 |
| Full Name | Jawed Ehsan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1100 Larkin Ave, Elgin, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114901501 | NPI | - | NPPES |
| 04532390 | Other | IL | BCBS |
| 04532181 | Other | IL | BLUE CROSS BLUE SHIELD |
| P00090413 | Other | RAILROAD | |
| 209598 | Other | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (Illinois) | Secondary |
| 207R00000X | Internal Medicine | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jawed Ehsan, MD P O Box 3412, Oak Brook, IL 60522-3412 Ph: (773) 343-9844 | Jawed Ehsan, MD 1100 Larkin Ave, Elgin, IL 60123-5272 Ph: (847) 742-0165 |
News Archive
A team of radiation oncologists at the Zucker School of Medicine at Hofstra/Northwell in the United States aimed to determine if COVID-19 infected cancer patients receiving radiation therapy (RT) have any different outcome than non-infected patients.
Bolder BioTechnology, Inc. today announced that it has been awarded a total of $1.2 million in Qualifying Therapeutic Discovery Project Grants. Grants were awarded for qualified investments under the Qualifying Therapeutic Discovery Project Tax Credit Program, which authorized up to $1 billion in tax credits or grants to biopharmaceutical companies with 250 or fewer employees.
"The results of this study show that fearless behavior in children can be identified and is related to neurological and genetic predisposition. This type of behavior has less correlation - at least in infancy - with standards of educational processes or parenting practice," says Dr. Inbal Kivenson-Baron, who carried out the study.
Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated OMONTYS (peginesatide) Injection, an erythropoiesis-stimulating agent (ESA), for the treatment of anemia due to chronic kidney disease (CKD) in adult dialysis patients.
› Verified 5 days ago
Aamir A Memon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1710 N Randall Rd Ste 330, Elgin, IL 60123 Phone: 847-531-5911 Fax: 847-531-5922 | |
Dr. Vanessa Alvarez, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1710 N Randall Rd Ste 260, Elgin, IL 60123 Phone: 847-931-7900 | |
Jeffrey Louis Garb, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1710 N. Randall Rd., Suite 250, Elgin, IL 60123 Phone: 847-888-1914 Fax: 847-888-1925 | |
Dr. Rajini Manjunath, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1710 N Randall Rd, Ste 300, Elgin, IL 60123 Phone: 847-931-0909 Fax: 847-931-0939 | |
Dr. Wesley Daniel Roberts, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1425 N Randall Rd, Elgin, IL 60123 Phone: 224-783-8998 | |
Dr. Timothy Wang, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2000 Larkin Ave, #100, Elgin, IL 60123 Phone: 847-888-2320 Fax: 847-888-2591 | |
Archana Goel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1710 N Randall Rd Ste 200, Elgin, IL 60123 Phone: 847-214-5740 |